Evidence & Innovation
FDA releases guiding principles for AI, ML
Last month, the FDA released 10 guiding principles to promote the safe and effective development of medical devices that use artificial intelligence and machine learning. The FDA and its UK and Canadian counterparts said the principles are intended to lay the foundation for Good Machine Learning Practice (GMLP). AI and ML technologies have the potential to radically expand the health care industry—but their complexity also presents unique considerations. The principles identify points at which international standards organizations and other collaborative bodies could work to advance GMLP. (Healthcare IT News; 10 guiding principles)
In Case You Missed It!
GTMRx Update: Educating Employers as Health Plan Sponsors
Advocacy in Action
GTMRx is pleased to announce that we have launched our Advocacy Letters and Policy Documents page on the GTMRx website. Advocacy is a core component of the GTMRx Institute’s mission, and our policy positions are aimed at advancing acceptance and recognition of the importance of creating a systematic, evidence-based approach to medications and their rational use through CMM in practice. To advance our efforts, comments are submitted to the Centers for Medicare and Medicaid Services (CMS), members of Congress, the Administration, and other public sector payers (OPM) as appropriate.
- Pharmacy Benefit Managers (PBMs)
- Medical carriers
- Benefit consultants
- Solution providers (PGx, others)